
Global COVID-19 Rapid Diagnostic Test Kit Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global COVID-19 Rapid Diagnostic Test Kit market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The COVID-19 Rapid Diagnostic Test Kit is divided into COVID-19 Rapid Diagnostic Test Kit and COVID-19 Antigen Rapid Test Kit according to the detection components.
The COVID-19 Rapid Diagnostic Test Kit market has been driven by several factors:
Urgent Need for Rapid Testing: The rapid spread of the COVID-19 virus required fast and accurate diagnostic tools to identify infected individuals quickly. Rapid diagnostic test kits provide results within a short period, enabling timely isolation and treatment.
Mass Testing and Screening Efforts: Many countries and regions initiated mass testing and screening campaigns to identify and isolate infected individuals. Rapid diagnostic test kits were crucial in facilitating these large-scale testing efforts.
Ease of Use and Accessibility: Rapid test kits are often designed to be user-friendly and can be administered without the need for specialized equipment or trained personnel. This accessibility made them valuable in various settings, including remote or resource-limited areas.
Quick Results: The ability to provide results within minutes to hours is a significant advantage of rapid test kits. This speed aids in reducing the time individuals spend waiting for results and allows for faster decision-making.
Surge in Demand: The global demand for COVID-19 testing, especially during outbreaks or waves of infections, significantly increased the demand for rapid diagnostic test kits.
Supplementing PCR Testing: While PCR tests are considered the gold standard for COVID-19 diagnosis, they can be time-consuming and require laboratory infrastructure. Rapid test kits provide a complementary approach, especially for initial screenings and quick results.
Travel and Border Control: Rapid diagnostic test kits have been used in many countries as part of travel and border control measures. They allow for on-the-spot testing of travelers and can contribute to reducing the spread of the virus across borders.
Employment and Public Spaces: Many workplaces, schools, and public spaces require regular testing to ensure safety. Rapid diagnostic test kits have been instrumental in monitoring and managing COVID-19 in these environments.
This report is a detailed and comprehensive analysis for global COVID-19 Rapid Diagnostic Test Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global COVID-19 Rapid Diagnostic Test Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global COVID-19 Rapid Diagnostic Test Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global COVID-19 Rapid Diagnostic Test Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global COVID-19 Rapid Diagnostic Test Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for COVID-19 Rapid Diagnostic Test Kit
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global COVID-19 Rapid Diagnostic Test Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include RayBiotech Life, Aurora Biomed, SD Biosensor, INSTI, CTK Biotech, SBL Testing Technologies, Biopanda, Roche Diagnostics, JOYSBIO, Abingdon Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
COVID-19 Rapid Diagnostic Test Kit market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Antibody Rapid Test Kit
Antigen Rapid Test Kit
Market segment by Application
Hospital
Company
School
Home
Others
Major players covered
RayBiotech Life
Aurora Biomed
SD Biosensor
INSTI
CTK Biotech
SBL Testing Technologies
Biopanda
Roche Diagnostics
JOYSBIO
Abingdon Health
TestLine Clinical Diagnostics
Assay Genie
Nadal-test
Panodyne
Luminex
Abbott
AESKU.GROUP
ARISTA® Biotech
iHealth
Quidel
ACCESS BIO
AUISET
Biotest Biotech
Hangzhou AllTest Biotech
ACON Biotech
Lepu Medical Technology
BGI
Phase Scientific
Assure Tech
BIOHIT Healthcare (Hefei)
Artron Laboratories
Philosys
Innovation Scientific
GenBody Inc
Medriva
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe COVID-19 Rapid Diagnostic Test Kit product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of COVID-19 Rapid Diagnostic Test Kit, with price, sales quantity, revenue, and global market share of COVID-19 Rapid Diagnostic Test Kit from 2020 to 2025.
Chapter 3, the COVID-19 Rapid Diagnostic Test Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the COVID-19 Rapid Diagnostic Test Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and COVID-19 Rapid Diagnostic Test Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of COVID-19 Rapid Diagnostic Test Kit.
Chapter 14 and 15, to describe COVID-19 Rapid Diagnostic Test Kit sales channel, distributors, customers, research findings and conclusion.
The COVID-19 Rapid Diagnostic Test Kit is divided into COVID-19 Rapid Diagnostic Test Kit and COVID-19 Antigen Rapid Test Kit according to the detection components.
The COVID-19 Rapid Diagnostic Test Kit market has been driven by several factors:
Urgent Need for Rapid Testing: The rapid spread of the COVID-19 virus required fast and accurate diagnostic tools to identify infected individuals quickly. Rapid diagnostic test kits provide results within a short period, enabling timely isolation and treatment.
Mass Testing and Screening Efforts: Many countries and regions initiated mass testing and screening campaigns to identify and isolate infected individuals. Rapid diagnostic test kits were crucial in facilitating these large-scale testing efforts.
Ease of Use and Accessibility: Rapid test kits are often designed to be user-friendly and can be administered without the need for specialized equipment or trained personnel. This accessibility made them valuable in various settings, including remote or resource-limited areas.
Quick Results: The ability to provide results within minutes to hours is a significant advantage of rapid test kits. This speed aids in reducing the time individuals spend waiting for results and allows for faster decision-making.
Surge in Demand: The global demand for COVID-19 testing, especially during outbreaks or waves of infections, significantly increased the demand for rapid diagnostic test kits.
Supplementing PCR Testing: While PCR tests are considered the gold standard for COVID-19 diagnosis, they can be time-consuming and require laboratory infrastructure. Rapid test kits provide a complementary approach, especially for initial screenings and quick results.
Travel and Border Control: Rapid diagnostic test kits have been used in many countries as part of travel and border control measures. They allow for on-the-spot testing of travelers and can contribute to reducing the spread of the virus across borders.
Employment and Public Spaces: Many workplaces, schools, and public spaces require regular testing to ensure safety. Rapid diagnostic test kits have been instrumental in monitoring and managing COVID-19 in these environments.
This report is a detailed and comprehensive analysis for global COVID-19 Rapid Diagnostic Test Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global COVID-19 Rapid Diagnostic Test Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global COVID-19 Rapid Diagnostic Test Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global COVID-19 Rapid Diagnostic Test Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global COVID-19 Rapid Diagnostic Test Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for COVID-19 Rapid Diagnostic Test Kit
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global COVID-19 Rapid Diagnostic Test Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include RayBiotech Life, Aurora Biomed, SD Biosensor, INSTI, CTK Biotech, SBL Testing Technologies, Biopanda, Roche Diagnostics, JOYSBIO, Abingdon Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
COVID-19 Rapid Diagnostic Test Kit market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Antibody Rapid Test Kit
Antigen Rapid Test Kit
Market segment by Application
Hospital
Company
School
Home
Others
Major players covered
RayBiotech Life
Aurora Biomed
SD Biosensor
INSTI
CTK Biotech
SBL Testing Technologies
Biopanda
Roche Diagnostics
JOYSBIO
Abingdon Health
TestLine Clinical Diagnostics
Assay Genie
Nadal-test
Panodyne
Luminex
Abbott
AESKU.GROUP
ARISTA® Biotech
iHealth
Quidel
ACCESS BIO
AUISET
Biotest Biotech
Hangzhou AllTest Biotech
ACON Biotech
Lepu Medical Technology
BGI
Phase Scientific
Assure Tech
BIOHIT Healthcare (Hefei)
Artron Laboratories
Philosys
Innovation Scientific
GenBody Inc
Medriva
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe COVID-19 Rapid Diagnostic Test Kit product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of COVID-19 Rapid Diagnostic Test Kit, with price, sales quantity, revenue, and global market share of COVID-19 Rapid Diagnostic Test Kit from 2020 to 2025.
Chapter 3, the COVID-19 Rapid Diagnostic Test Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the COVID-19 Rapid Diagnostic Test Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and COVID-19 Rapid Diagnostic Test Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of COVID-19 Rapid Diagnostic Test Kit.
Chapter 14 and 15, to describe COVID-19 Rapid Diagnostic Test Kit sales channel, distributors, customers, research findings and conclusion.
Table of Contents
187 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: COVID-19 Rapid Diagnostic Test Kit by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.